TQB-3562

N/A

Report date: 2025/03/07 13:56:55
NME

Base Information

Drug NameTQB-3562
Drug Alias NameTQB3562TQB-3562
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsTryptophan 2,3-dioxygenase inhibitors
TargetsIndoleamine 2,3-dioxygenaseTryptophan 2,3-dioxygenase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdLianyungang Runzhong Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A